Artimplant: Artelon(R) CMC Spacer Arthro for Arthroscopic Surgery Receives Regulatory Clearance for Marketing in the USA

STOCKHOLM, Sweden--(BUSINESS WIRE)--The biomaterials company Artimplant (STO:ARTIB) receives clearance for marketing Artelon® CMC Spacer Arthro, the company’s first product for keyhole surgery, in the USA. The product is indicated for thumb base osteoarthritis as Artelon® CMC Spacer. Small Bone Innovations, the licensee of Artimplant, now gets the opportunity to market the product at its domestic market USA.